Cleared Traditional

K072500 - ONE STEP HCG URINE/SERUM TEST

K072500 is the FDA 510(k) clearance for ONE STEP HCG URINE/SERUM TEST by Guangzhou Wondfo Biotech Co., Ltd.. It is a Class 2 Chemistry device (product code DHA) cleared through the Traditional 510(k) pathway after a 594-day FDA review.

K072500 · Guangzhou Wondfo Biotech Co., Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
594d
Days
Class 2
Risk

K072500 is an FDA 510(k) clearance for the ONE STEP HCG URINE/SERUM TEST. Classified as System, Test, Human Chorionic Gonadotropin (product code DHA), Class II - Special Controls.

Submitted by Guangzhou Wondfo Biotech Co., Ltd. (Yardley, US). The FDA issued a Cleared decision on April 21, 2009 after a review of 594 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Guangzhou Wondfo Biotech Co., Ltd. devices

Submission Details

510(k) Number K072500 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 05, 2007
Decision Date April 21, 2009
Days to Decision 594 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
506d slower than avg
Panel avg: 88d · This submission: 594d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHA System, Test, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DHA System, Test, Human Chorionic Gonadotropin

All 42
Devices cleared under the same product code (DHA) and FDA review panel - the closest regulatory comparables to K072500.
Diazyme DZ-Lite Total beta-hCG Test System
K163418 · Diazyme Laboratories · Aug 2017
ACCESS TOTAL BHCG (5TH IS)
K130020 · Beckman Coulter, Inc. · Oct 2013
LIAISON XL HCG
K131037 · DiaSorin, Inc. · Sep 2013
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B-HCG II REAGENT PACK, CALIBRATORS, RANGE VERIFIERS
K063720 · Ortho-Clinical Diagnostics · Apr 2007
DIMENSION VISTA (TM) BHCG FLEX(R) REAGENT CARTRIDGE, AND BHCG CALIBRATOR, MODEL# K6430,KC632
K063754 · Dade Behring, Inc. · Feb 2007
STRATUS CS ACUTE CARE BETAHCG AND NT-PROBNP TESTPAK AND TESTPAK ASSAY, CALPAK AND DILPAK
K060548 · Dade Behring, Inc. · Apr 2006